Perceptive Advisors as of Sept. 30, 2022
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 116 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 8.3 | $286M | 27M | 10.44 | |
Mirati Therapeutics | 5.6 | $195M | 2.8M | 69.84 | |
Cerevel Therapeutics Hldng I (CERE) | 5.3 | $184M | 6.5M | 28.26 | |
Global Blood Therapeutics In | 4.6 | $158M | 2.3M | 68.10 | |
Amylyx Pharmaceuticals (AMLX) | 4.5 | $154M | 5.5M | 28.15 | |
Lianbio Sponsored Ads (LIANY) | 3.3 | $115M | 58M | 2.00 | |
Cincor Pharma | 3.1 | $109M | 3.3M | 32.82 | |
Bellus Health Com New | 3.1 | $108M | 10M | 10.56 | |
Crinetics Pharmaceuticals In (CRNX) | 3.0 | $105M | 5.3M | 19.64 | |
Springworks Therapeutics (SWTX) | 2.9 | $99M | 3.5M | 28.53 | |
Iovance Biotherapeutics (IOVA) | 2.8 | $98M | 10M | 9.58 | |
Relmada Therapeutics (RLMD) | 2.6 | $88M | 2.4M | 37.02 | |
Prometheus Biosciences | 2.5 | $87M | 1.5M | 59.01 | |
Xenon Pharmaceuticals (XENE) | 2.2 | $77M | 2.1M | 36.10 | |
Aldeyra Therapeutics (ALDX) | 1.8 | $61M | 11M | 5.34 | |
Meiragtx Holdings (MGTX) | 1.7 | $59M | 7.0M | 8.41 | |
Inhibrx | 1.5 | $52M | 2.9M | 17.95 | |
Verona Pharma Sponsored Ads (VRNA) | 1.5 | $52M | 5.0M | 10.22 | |
Cogent Biosciences (COGT) | 1.4 | $48M | 3.2M | 14.92 | |
Arcellx Common Stock (ACLX) | 1.3 | $46M | 2.5M | 18.77 | |
Travere Therapeutics Note 2.250% 3/0 (Principal) | 1.3 | $46M | 45M | 1.02 | |
Lyra Therapeutics (LYRA) | 1.3 | $46M | 9.1M | 5.01 | |
Albireo Pharma | 1.3 | $46M | 2.4M | 19.36 | |
Female Health (VERU) | 1.3 | $45M | 3.9M | 11.52 | |
Relay Therapeutics (RLAY) | 1.3 | $44M | 1.9M | 22.37 | |
Seagen | 1.3 | $43M | 317k | 136.83 | |
Rapt Therapeutics (RAPT) | 1.2 | $41M | 1.7M | 24.06 | |
Vbi Vaccines Inc Cda Com New | 1.1 | $37M | 52M | 0.71 | |
Treace Med Concepts (TMCI) | 1.0 | $35M | 1.6M | 22.07 | |
Nuvalent Inc-a (NUVL) | 0.9 | $32M | 1.7M | 19.44 | |
Establishment Labs Holdings Ord (ESTA) | 0.9 | $32M | 578k | 54.61 | |
BioMarin Pharmaceutical (BMRN) | 0.8 | $29M | 337k | 84.77 | |
Sarepta Therapeutics (SRPT) | 0.8 | $28M | 253k | 110.54 | |
Edwards Lifesciences (EW) | 0.8 | $27M | 330k | 82.63 | |
Zymeworks | 0.8 | $27M | 4.4M | 6.15 | |
Adma Biologics (ADMA) | 0.8 | $27M | 11M | 2.43 | |
Miragen Therapeutics (VRDN) | 0.7 | $25M | 1.2M | 20.51 | |
Apellis Pharmaceuticals (APLS) | 0.7 | $25M | 366k | 68.30 | |
Immatics SHS (IMTX) | 0.7 | $25M | 2.5M | 10.00 | |
Caremax Com Cl A | 0.7 | $24M | 3.4M | 7.09 | |
Tarsus Pharmaceuticals (TARS) | 0.6 | $22M | 1.3M | 17.12 | |
Revance Therapeutics (RVNC) | 0.6 | $22M | 809k | 27.00 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $22M | 331k | 64.99 | |
Nautilus Biotechnology (NAUT) | 0.6 | $19M | 9.1M | 2.12 | |
Cytek Biosciences (CTKB) | 0.6 | $19M | 1.3M | 14.72 | |
Outset Med (OM) | 0.5 | $19M | 1.2M | 15.93 | |
Iveric Bio | 0.5 | $19M | 1.0M | 17.94 | |
Harmony Biosciences Hldgs In (HRMY) | 0.5 | $18M | 412k | 44.29 | |
Arcus Biosciences Incorporated (RCUS) | 0.5 | $17M | 667k | 26.16 | |
Bridgebio Pharma (BBIO) | 0.5 | $17M | 1.7M | 9.94 | |
CryoLife (AORT) | 0.5 | $17M | 1.2M | 13.84 | |
Coherus Biosciences (CHRS) | 0.5 | $16M | 1.7M | 9.61 | |
Verrica Pharmaceuticals (VRCA) | 0.4 | $15M | 5.0M | 2.92 | |
Akero Therapeutics (AKRO) | 0.4 | $15M | 430k | 34.05 | |
Concert Pharmaceuticals I equity | 0.4 | $14M | 2.2M | 6.70 | |
Athira Pharma (ATHA) | 0.4 | $14M | 4.8M | 2.97 | |
Prothena Corp SHS (PRTA) | 0.4 | $14M | 230k | 60.63 | |
Dice Therapeutics | 0.4 | $14M | 687k | 20.28 | |
Hillevax (HLVX) | 0.4 | $13M | 765k | 17.09 | |
Rain Therapeutics | 0.4 | $12M | 2.5M | 4.88 | |
Astria Therapeutics (ATXS) | 0.3 | $12M | 1.3M | 9.04 | |
Axogen (AXGN) | 0.3 | $11M | 950k | 11.92 | |
Procept Biorobotics Corp (PRCT) | 0.3 | $11M | 264k | 41.46 | |
Neurocrine Biosciences (NBIX) | 0.3 | $11M | 100k | 106.21 | |
Morphic Hldg (MORF) | 0.3 | $10M | 363k | 28.30 | |
Chemocentryx | 0.3 | $10M | 193k | 51.66 | |
Landos Biopharma | 0.3 | $9.7M | 15M | 0.65 | |
Larimar Therapeutics (LRMR) | 0.3 | $9.2M | 2.9M | 3.20 | |
Singular Genomics Systems In | 0.3 | $8.8M | 3.5M | 2.50 | |
Rocket Pharmaceuticals (RCKT) | 0.2 | $8.0M | 500k | 15.96 | |
Kronos Bio (KRON) | 0.2 | $7.2M | 2.2M | 3.35 | |
Isoplexis Corp | 0.2 | $7.0M | 4.1M | 1.72 | |
Nevro (NVRO) | 0.2 | $7.0M | 150k | 46.60 | |
C4 Therapeutics Com Stk (CCCC) | 0.2 | $6.7M | 766k | 8.77 | |
Leap Therapeutics | 0.2 | $6.6M | 7.5M | 0.88 | |
Solid Biosciences | 0.2 | $6.3M | 13M | 0.47 | |
Revolution Medicines (RVMD) | 0.2 | $6.1M | 311k | 19.72 | |
Aclaris Therapeutics (ACRS) | 0.2 | $5.4M | 341k | 15.74 | |
Natera (NTRA) | 0.2 | $5.3M | 120k | 43.82 | |
Tricida Put Option | 0.2 | $5.2M | 500k | 10.48 | |
Inari Medical Ord (NARI) | 0.1 | $5.1M | 70k | 72.64 | |
Envveno Medical (NVNO) | 0.1 | $4.9M | 782k | 6.28 | |
Sema4 Holdings Corp Com Cl A | 0.1 | $4.4M | 5.0M | 0.88 | |
Somalogic Class A Com | 0.1 | $4.4M | 1.5M | 2.90 | |
Tyra Biosciences (TYRA) | 0.1 | $4.3M | 494k | 8.79 | |
Cti Biopharma | 0.1 | $4.3M | 735k | 5.82 | |
Athenex | 0.1 | $4.2M | 16M | 0.27 | |
Acumen Pharmaceuticals (ABOS) | 0.1 | $4.0M | 400k | 10.03 | |
Point Biopharma Global | 0.1 | $3.9M | 500k | 7.73 | |
Health Catalyst (HCAT) | 0.1 | $3.8M | 390k | 9.70 | |
Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.8M | 1.1M | 3.54 | |
Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.1 | $3.6M | 4.5M | 0.80 | |
Y Mabs Therapeutics (YMAB) | 0.1 | $3.1M | 212k | 14.42 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $3.0M | 1.5M | 1.97 | |
Absci Corp (ABSI) | 0.1 | $2.8M | 894k | 3.13 | |
Poseida Therapeutics I (PSTX) | 0.1 | $2.6M | 750k | 3.53 | |
Clover Health Investments Com Cl A (CLOV) | 0.1 | $2.6M | 1.5M | 1.70 | |
Reata Pharmaceuticals Cl A | 0.1 | $2.5M | 100k | 25.13 | |
Quotient SHS | 0.1 | $2.4M | 16M | 0.15 | |
Science 37 Holdings | 0.1 | $2.4M | 1.5M | 1.61 | |
Fulcrum Therapeutics (FULC) | 0.1 | $2.4M | 294k | 8.09 | |
Travere Therapeutics (TVTX) | 0.1 | $2.2M | 91k | 24.64 | |
Pear Therapeutics | 0.1 | $1.8M | 901k | 2.04 | |
Dariohealth Corp Com New (DRIO) | 0.0 | $1.5M | 328k | 4.63 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $859k | 290k | 2.96 | |
Hyperfine Com Cl A (HYPR) | 0.0 | $751k | 927k | 0.81 | |
Sonendo (SONX) | 0.0 | $655k | 612k | 1.07 | |
Provention Bio | 0.0 | $498k | 111k | 4.50 | |
Icosavax | 0.0 | $296k | 94k | 3.16 | |
Motus Gi Hldgs Com New | 0.0 | $221k | 90k | 2.45 | |
Eqrx *w Exp 12/17/202 | 0.0 | $205k | 250k | 0.82 | |
Agile Therapeutics Com New | 0.0 | $158k | 532k | 0.30 | |
Caremax *w Exp 06/08/202 | 0.0 | $113k | 60k | 1.88 | |
Neptune Wellness Solutions I Com New | 0.0 | $87k | 57k | 1.52 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $31k | 167k | 0.19 | |
Surrozen | 0.0 | $12k | 6.0k | 1.99 |